Ablynx NV Says Offer By Novo Nordisk To Acquire Co. Fundamentally Undervalues The Co. And Its Future Prospects, Believes The Proposed Consideration And A Complex Instrument Like A CVR Doesn't Constitute A Basis For Further Discussions At This Time